Baylis Medical Opens MedTech Facility in Costa Rica

What To Know

  • Investing with purpose is taking on greater relevance for industry leaders and the country continues to lead in investment destinations noted for human talent, target market proximity, and supplier availability, based on extremely innovative concepts of sustainable production.
  • Our team in Costa Rica will be instrumental in helping us serve patients through leading cardiology devices that will improve the lives of people around the world for years to come,”.

Baylis Medical is a Canadian company and leader in the development and commercialization of innovative medical devices in cardiology. Today the company announced its arrival in Costa Rica.

Costa Rica is committed to strengthening our productive sectors with high added value, via products and services that revolutionize the market while simultaneously generating quality formal employment – jobs with lasting roots and consistent opportunities for growth.

“With the opening of the Baylis Medical, the country, once again, focuses its trajectory for growth and innovation on the medical device industry. We are very proud that Baylis Medical has put its trust in Costa Rica to launch such an important plant, which will serve international markets through a strategic and transformative vision. We are very enthusiastic about this news and, from all of us at the Ministry of Foreign Trade, we wish Baylis Medical the greatest success,” commented Andrés Valenciano, Costa Rican Minister of Foreign Trade.

“We are proud to be expanding Baylis Medical with a new facility in Costa Rica. Our team in Costa Rica will be instrumental in helping us serve patients through leading cardiology devices that will improve the lives of people around the world for years to come,” said Kris Shah, President of Baylis Medical.

Jorge Sequeira, CINDE’s managing director, commented, “Thanks to its acknowledged track record in life sciences, the country has 12 of the world’s 30 leading medical firms. Today, Baylis Medical joins the cluster, which by the end of 2020 consisted of 81 companies and generated an accumulated total of more than 38,000 jobs in Costa Rica. Investing with purpose is taking on greater relevance for industry leaders and the country continues to lead in investment destinations noted for human talent, target market proximity, and supplier availability, based on extremely innovative concepts of sustainable production.”

Baylis Medical highlighted Costa Rica’swell-established medical device manufacturing sector, and its highly skilled workforce for its investment decision. In terms of core values, Costa Rica’s similarities to Canada made the country attractive for its expansion.

People interested in applying for one of the company’s positions may do so at costarica@baylismedical.com. The company is currently looking for a core team that will support the operation setup. It searches for passionate, energetic, and team-oriented staff. In the new year, Baylis Medical will begin building a team of manufacturing employees to support production of its world-leading cardiology devices.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy